期刊
COLLOIDS AND SURFACES B-BIOINTERFACES
卷 193, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.colsurfb.2020.111055
关键词
Drug release; Adsolubilization; Glyburide; Cell viability; Diabetes mellitus
资金
- CAPES
- University of Santiago de Compostela (USC), the PDSE-CAPES program
- USC, CETENE
- postgraduate program in Pharmaceutical Sciences (PPGCF-UFPE)
In this work, synthesis of sodium dodecyl sulfate (SDS) organomodified LDH Zn2Al carrying glibenclamide (GLIB) was performed in one step and in one-pot to obtain nanoparticles (NP). XRD data showed GLIB adsolubilization (d= 14.03 angstrom) and NP coating with Eudragit L100 (R). In addition, thermal and XRD data showed exfoliated/intercalated nanocomposite for NP S5 (LDH associated with SDS and Eudragit L100 (R)). LDH organophilization and GLIB intercalation reduced surface area (SBET 23.58m2/g) and NP size (469 nm). In addition, the change in zeta potential (-35.5 zeta) relative to pristine LDH (SBET 41.34m(2)/g, 688.8 nm and +14 zeta) indicated that LDH functionalization seems an appropriate approach to produce NP with greater colloidal stability and enhanced functionality. The zinc release data from the LDH matrix (2.96 %+/- 0.002 ppm) showed the effectiveness of the coating in acid medium (pH 1.2) and the release data from GLIB showed the kinetics of release of zero order with release in simulated intestinal medium (pH 7.4) of 88 % and 73 % (24 h) for uncoated and coated NP, respectively. All NP were considered biocompatible in the WST-1 assay on BALB 3T3 fibroblast strains making these NP promising therapeutically.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据